Brazil medical cannabis import authorizations surge 29% amid regulated market expansion

Import permit growth signals rising demand in Brazil's medical cannabis sector as regulatory infrastructure matures.

FILE — harvest · My 420 Tours / CC BY-SA 4.0

Brazil's medical cannabis import authorizations climbed 29% according to reporting from the International Cannabis Business Conference, underscoring accelerating demand within the country's regulated medical market. The increase arrives as Brazil has progressively opened its cannabis framework—authorizing domestic cultivation for the first time in early 2026 and establishing institutional infrastructure including a germplasm bank for research.

The import surge suggests patient enrollment and clinical uptake are outpacing domestic supply capacity. Brazil's medical cannabis patient population reached 873,000 as of May 2026, creating continued reliance on imports despite domestic cultivation authorization. However, the regulatory environment remains complex, with ongoing policy debates over THC limits for hemp and enforcement activities targeting illicit cultivation.

Watch for domestic production ramp timelines: as authorized cultivators begin harvesting, import volumes may stabilize or decline, signaling whether Brazil's medical market is transitioning toward self-sufficiency or expanding faster than internal supply can scale.